Malta - English - Medicines Authority

dolorgiet gmbh & co. kg otto-von-guericke-str. 1, 53757 sankt augustin / bonn, germany - benzalkonium chloride, xylometazoline hydrochloride - nasal drops, solution - benzalkonium chloride 5 mg/ml xylometazoline hydrochloride 0.05 % (w/v) - nasal preparations

New Zealand - English - Medsafe (Medicines Safety Authority)

novartis consumer health australasia pty ltd (nz) - xylometazoline hydrochloride 0.05%{relative};   - nasal drops - 0.5 mg/ml - active: xylometazoline hydrochloride 0.05%{relative}   excipient: benzalkonium chloride dibasic sodium phosphate dodecahydrate disodium edetate dihydrate monobasic sodium phosphate dihydrate purified water sodium chloride

New Zealand - English - Medsafe (Medicines Safety Authority)

novartis consumer health australasia pty ltd (nz) - xylometazoline hydrochloride 0.05%{relative};   - nasal spray solution - 0.5 mg/ml - active: xylometazoline hydrochloride 0.05%{relative}   excipient: benzalkonium chloride dibasic sodium phosphate dodecahydrate disodium edetate dihydrate monobasic sodium phosphate dihydrate purified water sodium chloride

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

novartis consumer health s.a. - xylometazoline (xylometazoline hydrochloride) - drops nasal - 0,5mg/ml

Malta - English - Medicines Authority

novartis consumer health uk limited - xylometazoline hydrochloride - nasal spray, solution - xylometazoline hydrochloride 0.05 % (w/v) - nasal preparations

Malta - English - Medicines Authority

haleon hellas single member societe anonyme, under the distinctive title of haleon hellas, 274, kifissias ave, 15232 chalandri, athens, greece - xylometazoline hydrochloride - nasal spray, solution - xylometazoline hydrochloride 0.5 mg/ml - nasal preparations

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

biodeal pharmaceuticals pvt. ltd. - xylometazoline (xylometazoline hydrochloride) - drops nasal - 0,5mg/ml

Malta - English - Medicines Authority

novartis consumer health uk limited - xylometazoline hydrochloride 0.05 % (w/v) - nasal drops, solution

United States - English - NLM (National Library of Medicine)

rebel distributors corp - ciprofloxacin hydrochloride (unii: 4ba73m5e37) (ciprofloxacin - unii:5e8k9i0o4u) - ciprofloxacin hydrochloride 3.5 mg in 1 ml - ciprofloxacin hydrochloride ophthalmic solution is indicated for the treatment of infections caused by susceptible strains of the designated microorganisms in the conditions listed below: corneal ulcers: - pseudomonas aeruginosa - serratia marcescens* - staphylococcus aureus - staphylococcus epidermidis - streptococcus pneumoniae - streptococcus (viridans group)* conjunctivitis: - haemophilus influenzae - staphylococcus aureus - staphylococcus epidermidis - streptococcus pneumoniae *efficacy for this organism was studied in fewer than 10 infections. a history of hypersensitivity to ciprofloxacin or any other component of the medication is a contraindication to its use. a history of hypersensitivity to other quinolones may also contraindicate the use of ciprofloxacin.

United States - English - NLM (National Library of Medicine)

stat rx usa llc - ciprofloxacin hydrochloride (unii: 4ba73m5e37) (ciprofloxacin - unii:5e8k9i0o4u) - ciprofloxacin hydrochloride 3.5 mg in 1 ml - ciprofloxacin hydrochloride ophthalmic solution is indicated for the treatment of infections caused by susceptible strains of the designated microorganisms in the conditions listed below: corneal ulcers: pseudomonas aeruginosa serratia marcescens* staphylococcus aureus staphylococcus epidermidis streptococcus pneumoniae streptococcus (viridans group)* conjunctivitis: haemophilus influenzae staphylococcus aureus staphylococcus epidermidis streptococcus pneumoniae *efficacy for this organism was studied in fewer than 10 infections. a history of hypersensitivity to ciprofloxacin or any other component of the medication is a contraindication to its use. a history of hypersensitivity to other quinolones may also contraindicate the use of ciprofloxacin. safety and effectiveness in pediatric patients below the age of 1 year have not been established. although ciprofloxacin and other quinolones cause arthropathy in immature animals after oral administration, topical ocular administration of ciprofloxacin to immature